HomeTagsInterim Data

Interim Data

Biotechnology

BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability

PR Newswire - November 18, 2022

BioVaxys Technology Corp. is pleased to announce that interim results from its ongoing preclinical of BVX-1021, the Company's vaccine for SARS-CoV-1 ("SARS1") which is...

Biotechnology

Moleculin Announces Preliminary Third Cohort Interim Data in Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases

PR Newswire - December 28, 2021

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary interim...